Home | Links | Contact Us | More About Intellectual Property | Bookmark
Search patents:
Home Vasodialators 1-4-dihydro-4-oxo-3-quinoline-derivatives-as-selectively-toxic-mammalian-antibacterial-agents

 2-Azasfiro[4.(3+N)]-3-carboxylic acid derivatives, a process for their preparation, agents containing these derivatives and their use
We claim: 1. A compound of the formula I ##STR11## in which n denotes 1, 2, 3 or 4, R denotes (C....


 N-Acyl hexahydroindole-2-carboxylic acids and anti-hypertensive use thereof
We claim: 1. A compound of the formula I, ##STR24## in which n denotes 0 to 1, R denotes hydrogen, (...


 Bicyclic amino acids as intermediates in the preparation of tricyclic amino acids and processes for their preparation
We claim: 1. A compound of the formula III ##STR19## in which A denotes --CH.dbd.CH-- or --CH.sub.2 ...


 Substituted N-carboxymethyl-aminoacylaminoalkanoic acids useful as antihypertensive agents
OF THE INVENTION AND PREFERRED EMBODIMENTS In its broadest aspect, the present invention relates ...


 Racemates of optically active bicyclic imino-alpha-carboxylic esters
We claim: 1. A diasteromic salt of i. a bicyclic imino-.alpha.-carboxylic ester of the formulae Ia ...


 Disubstituted proline derivatives
We claim: 1. A compound of the formula I ##STR15## in which R.sup.1 and R.sup.2 together represent ...


 Derivatives of cis, endo-2-azabicyclo[5.3.0]decane-3-carboxylic acid, and their use for treating hypertension
We claim: 1. A compound of the formula I ##STR11## in which the hydrogen atoms on the bridgehead C ...


 Carboxyalkyl dipeptides and anti-hypertensive use thereof
We claim: 1. A compound represented by the formula ##STR12## and the pharmaceutically acceptable ...


 Optically active bicyclic imino-alpha-carboxylic esters
We claim: 1. A compound of the formulae Ia or Ib essentially free of its racemate, and salts of ...


 5-HT.sub.3 receptor antagonists for treatment of cough and bronchoconstriction
I claim: 1. A method of treatment of cough and/or bronchoconstriction in mammals, which method ...


 1,4-dihydro-4-oxo-3-quinoline derivatives as selectively toxic mammalian antibacterial agents

Details
Inventors: McGuirk, Paul R.;
Assignee: Pfizer Inc. (New York, NY)
Primary Examiner: Bernhardt; Emily
Assistant Examiner:
Attorney, Agent or Firm: Richardson; Peter C., Ginsburg; Paul H., Strassburger; Philip C.

Compounds of the formula ##STR1## and the pharmaceutically acceptable salts thereof, wherein Q, X and R are as defined below. The compounds of formula I are broad spectrum mammalian antibacterial agents and exhibit favorable selectivity against procaryotic cells.

DETAILED DESCRIPTION OF THE INVENTION Compounds of the formula I may be prepared as illustrated in the following reaction scheme.
##STR6## Referring to the above reaction scheme, compounds of the formula I, wherein Q is hydrogen and R and Y are as defined above, may be prepared by reacting a compound of the formula II, wherein R and Y are as defined above and Hal is chloro, bromo, fluoro or iodo, with a compound of the formula III.
The reaction may be performed in the absence of a solvent or in the presence of a polar, reaction inert solvent such as acetonitrile, tetrahydrofuran, ethanol, chloroform, dimethylformamide, pyridine, or water, or mixtures thereof.
The reaction is preferably carried out in the presence of a base such as an alkali metal or alkaline earth metal carbonate or bicarbonate, or a secondary or tertiary amine such as triethylamine, pyridine or picoline.
The preferred reaction temperature is from about 60.
degree.
to about 100.
degree.
C.
, but temperatures from about 10.
degree.
to about 150.
degree.
C.
are generally suitable.
The starting materials of formula II are known in the art, e.
g.
as disclosed in European Patent Application 0230295A2.
Compounds of the formula III, wherein Q is hydrogen, may be made as described in U.
S.
Pat.
No.
3,947,445 and in J.
Org.
Chem.
, 31, 1059 (1966).
Compounds of the formula I wherein Q is methyl may be prepared from the corresponding compounds of the formula I wherein Q is hydrogen by conventional methylation procedurs.
For example, one standard methylation procedure known in the art involves the use of formic acid and paraformaldehyde.
According to this procedure, a mixture of an alkali or alkaline earth metal formate (preferably sodium formate), formic acid (preferably 87% formic acid), formalin (preferably 37% formalin), and a compound of the formula I wherein Q is hydrogen are reacted to yield a compound of the formula I wherein Q is methyl.
The reaction is typically carried out by stirring the reactants for approximately 0.
5 to 24 hours, preferably about 2 hours, at a temperature of from about 80



Related patents
  Vaginal sponge delivery system
These and other objects of the invention are achieved in a product which broadly comprises (a) a sealed, air-tight package, enclosing therein (b) a sponge impregnated ...
  Controlled release formulation
What is claimed is: 1. In a controlled release angiotensin converting enzyme inhibitor formulation in the form of an uncoated tablet from which upon ingestion ...
  Formulations providing three distinct releases
We claim: 1. A therapeutic composition for oral administration consisting essentially of a pharmaceutical gelatin capsule containing film coated spheroids, which ...
  Floating sustained release therapeutic compositions
OF THE INVENTION According to the present invention, therapeutic dosage forms have now been discovered which are easy to prepare, provide sustained release of contained ...
  Solid oral dosage forms of ifosfamide
OF PREFERRED EMBODIMENTS The invention is illustrated by the following examples: EXAMPLE 1 Ifosfamide capsule mass In accordance with the invention, the capsule mass is ...
  [(benzodioxan, benzofuran or benzopyran) alkylamino] alkyl substituted guanidines
We claim: 1. A compound of the formula: ##STR259## a pharmaceutically acceptable acid addition salt thereof, or a stereochemically isomeric form thereof, wherein: X is O,...
  Methods for treating dermatitis using descarboethoxyloratadine
OF THE INVENTION The present invention encompasses a method of treating allergic asthma in a human while avoiding the concomitant liability of adverse side-effects ...
  Fat emulsions containing isocarbacyclin
What is claimed is: 1. A pharmaceutical prostaglandin emulsion comprising: a mixture of vegetable oil, phospholipid, water, and a pharmaceutically effective amount of at ...
  Dermal pharmaceutical preparations
OF THE INVENTION The support which can be used in the present invention functions to retain a layer of a pressure-sensitive adhesive containing a drug and is selected ...
  Substituted iminodiacids, their preparation and pharmaceutical compositions containing them
We claim: 1. A compound selected from the group consisting of iminodiacid compounds having the formula: ##STR20## wherein R.sub.1 represents lower-alkyl having 1 to 4 ...

0.024

Archive: All patents - Links

Copyright (c)2006 Eipa-patents.org - All rights reserved